Union Chimique Belge Investor
UCB focuses on research and development of medications centered on epilepsy, parkinson's disease, and crohn's disease. Their research and development activities in neurology, immunology, and other areas.
Number Of Exists:
5
Investor Type:
Angel Investors
Employee Number:
10001+
Headquarters:
Brussels, Brussels Hoofdstedelijk Gewest, Belgium, Europe
Founded Date:
1928-01-01
Industry:
Biopharma & Life Science Tools
Phone Number:
+32 2 559 99 99
Number Of Investment/Funding Rounds:
11
City:
Brussels
Region:
Brussels Hoofdstedelijk Gewest
Country:
Belgium
Founders:
Emmanuel Janssen